Life WhispererLife WhispererLife WhispererLife Whisperer
  • Home
  • Products
    • Life Whisperer Genetics
    • Life Whisperer Viability
    • Life Whisperer Genetics
    • Life Whisperer Oocytes
    • Life Whisperer Endometrial Receptivity
  • Distribution
  • News & Science
    • Press
    • IVF-X
    • Publications
  • About
  • Request a Trial
  • Home
  • Products
    • Life Whisperer Embryo Quality
    • Life Whisperer Viability
    • Life Whisperer Genetics
    • Life Whisperer Oocytes
    • Life Whisperer Endometrial Receptivity
  • Distribution
  • News & Science
    • Press
    • IVF-X
    • Publications
  • About
  • Request a Trial
  • Home
  • Products
    • Life Whisperer Genetics
    • Life Whisperer Viability
    • Life Whisperer Genetics
    • Life Whisperer Oocytes
    • Life Whisperer Endometrial Receptivity
  • Distribution
  • News & Science
    • Press
    • IVF-X
    • Publications
  • About
  • Request a Trial

Novel AI algorithm enables scalable and automated assessment of embryo medical images across multiple camera systems

AI Healthcare company Presagen, in collaboration with US-based IVF clinic group Ovation Fertility, presented its novel self-annotating AI algorithm at the prestigious European ESHRE Fertility Conference, July 2020. Presagen’s Life Whisperer product analyzes images of an IVF patient’s embryos to identify which embryo is likely to lead to a pregnancy.

The novel algorithm enables its Life Whisperer embryo assessment product to operate robustly on vastly different camera systems, including standard microscope cameras and time-lapse imaging systems. The innovation allows Life Whisperer’s web-based AI to be reliably and scalably used in any clinic around the world using existing camera systems, without the need for additional expensive hardware. 

Unlike current embryo assessment algorithms, Life Whisperer does not require embryologists to perform time-consuming manual annotations on embryos images to operate. Life Whisperer’s AI is completely automated. Embryologists only need to drag-and-drop images of embryos onto the web application, and the AI automatically annotates the image and returns an assessment of the embryo’s viability to support the embryologist’s decision. The popular Life Whisperer Patient Report is then automatically created for patients, enabling greater transparency and evidence-base around embryo quality assessment and selection.

The abstract and presentation can be downloaded below.

Download presentation
Download abstract
Share
99

Related posts

August 16, 2023

Can analysis of embryo appearance using artificial intelligence provide insight into the sex of your baby, and help prevent male bias in IVF?


Read more
August 8, 2023

Independent study shows Life Whisperer’s AI can predict the viability of embryos that have previously been frozen


Read more
July 20, 2023

Life Whisperer Genetics AI shows robust performance at varying times and stages of embryo development


Read more
March 6, 2023

ISAR Presentation: AI Enhanced Fertility


Read more

Comments are closed.

HIPAA and GDPR compliant and ISO 13485 certified.

CE Logo

Life Whisperer Viability and Genetics are commercially available in Australia, Canada, Europe (EEA), UK, Japan, India, UAE, Hong Kong, Israel, Malaysia, Thailand, Vietnam, Singapore, New Zealand, Turkey, Trinidad & Tobago, and Guyana (not available in the USA).

Life Whisperer Genetics is commercially available in the USA.

For sale to healthcare professionals only.

© Life Whisperer Diagnostics Pty Ltd     Terms and conditions   |   Privacy Policy   |   Fair Use Policy
  • Home
  • Products
  • Distribution
  • News & Science
  • About
  • Request a Trial